TRACON to Report Second Quarter 2016 Company Highlights and Financial Results on August 10, 2016

20:00 EDT 2 Aug 2016 | Globe Newswire

SAN DIEGO, Aug. 03, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration and fibrotic diseases, announced today that it will report its second quarter 2016 financial and operating results after the close of U.S. financial markets on Wednesday, August 10, 2016. In addition, management will host a conference call to provide an update on corporate activities and discuss the quarterly financial results.

Conference call and webcast:
Date:    August 10, 2016
Time:    4:30 pm Eastern Time (1:30 pm Pacific Time)
Dial-in:    (855) 779-9066 (Domestic) or (631) 485-4859 (International)
Passcode:    59381366
Via web:; “Events and Presentation” section within the “Investors” section

A replay of the webcast will be available for 60 days on the website.


TRACON develops targeted therapies for cancer, ophthalmic and fibrotic diseases. The Company’s clinical-stage pipeline includes: TRC105, an endoglin antibody that is being developed for the treatment of multiple cancers; DE-122, the ophthalmic formulation of TRC105 that is being developed in wet AMD through a collaboration with Santen Pharmaceutical Company Ltd.; and TRC102, a small molecule that is being developed for the treatment of lung cancer and glioblastoma. To learn more about TRACON and its product candidates, visit TRACON's website at

Company Contact:	
Casey Logan		
Chief Business Officer	
(858) 550-0780 ext. 236

Investor Contact:
Andrew McDonald
LifeSci Advisors LLC

Primary Logo


More From BioPortfolio on "TRACON to Report Second Quarter 2016 Company Highlights and Financial Results on August 10, 2016"

Quick Search


Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...